4.60 USD
↘ 0.00 (0.11%)PRE MARKET (AS OF 05:22 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
Market: OPEN
Seres Therapeutics, Inc. (MCRB) trades at $4.60 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$4.60
High?$4.60
Low?$4.60
Prev. Close?$4.60
Volume?5
Avg. Volume?61.5K
VWAP?$4.60
Rel. Volume?0.00x
Bid / Ask
Bid?$3.89 × 100
Ask?$5.93 × 100
Spread?$2.04
Midpoint?$4.91
Valuation & Ratios
Market Cap?46.2M
Shares Out?10.0M
Float?7.1M
Float %?71.0%
P/E Ratio?N/A
P/B Ratio?1.34
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
47.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.65Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?5.05%Elevated
Short Interest?356.5K
Days to Cover?6.1
Free Float7.1M
Avg Daily Volume58.4K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.11Strong
Quick Ratio?2.11Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.34CHEAP▾
Peers100
S&P91
P/S?24.54HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?16.26HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-65.1%WEAK▾
S&P3
ROA?-22.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51295000
Enterprise Value?$30.6M
Fundamentals ratios updated end of day